Pharmaceutical Technology: Controlled Drug Release, Volume 2
Pharmaceutical Technology: Controlled Drug Release, Volume 2
Pharmaceutical Technology: Controlled Drug Release, Volume 2
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
98 CH. 8] TOPICAL RELEASE AND PERMEATION STUDIES<br />
Table 7—Computed parameters for Methocel® m atrix diffusion data through hairless mouse skin (up to 12 h)<br />
Table 8—Permeability rate of propranolol hydrochloride from Methocel® matrix diffusion study through hairless<br />
mouse skin (comparative data)<br />
a Concentration represents average of three determinations.<br />
b Statistical analysis performed by the F test and confidence interval (95%) methods: NS, statistically not significant; SS,<br />
statistically significant.<br />
coefficient value (3.0×10−7 cm2/s), compared with the emulsion base formulation with only 0.<br />
11×10 −7 cm 2 /s. In addition, the highest permeability coefficient of 1.90×10 −7 cm 2 /s was obtained<br />
for this formulation, compared with the emulsion-based sample with a value of 0.40×10−7 cm2/s.<br />
However, the partition coefficient is observed to be the lowest for the Methocel ® matrix<br />
formulation (0.38×10 −1 cm 2 /s) compared with the value of 2.30×10 −1 cm 2 /s obtained with the<br />
emulsion base formulation, which gave the minimum release of the drug. For higher drug release<br />
the formulation should possess relatively high permeability and diffusion coefficient.<br />
REFERENCES<br />
1 [] J.W.Black, A.F.Crowther, R.G. Shanks, I.H.Smith and A.C.Dornhost, Lancet, 1,1080(1964).<br />
2 [] J.W.Black, W.M.Duncan and R.G.Shanks, Br. J. Pharmacol., 25, 577 (1965).<br />
3 [] B.N.C.Prichard, Br. Med. J., 2, 725 (1964).<br />
4 [] B.N.C.Prichard, Br. Med. J., 1, 1227 (1964).<br />
5 [] F.A.Richards, Am. J. Cardiol., 18, 384 (1966).<br />
6 [] B.N.C.Prichard and P.N.S.Gillman, Am. J. Cardiol., 18, 387 (1966).